BIOGRAPHENE is a biotech startup dedicated to developing novel graphene-based drugs for neurodegenerative diseases. Our primary targets include Parkinson's disease, Alzheimer's disease, and Niemann-Pick disease type C (NPC). We are a spin-off company from Seoul National University and incorporated as a legal entity in the state of California starting in June 2020.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 555 W 5th St, 35th Floor,korea, Republic Of
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.bio-graphene.com
- Keywords
- Graphene, Nanotechnology, Nanomedicine.
- HQ
- Los Angeles, California
Biographene Questions
Biographene's website is http://www.bio-graphene.com
Biographene's LinkedIn profile is https://www.linkedin.com/company/biographene
Biographene has
3 employees.
View email and phone details for 3
employees at Biographene.
Biographene's industry is
Pharmaceutical Manufacturing
Biographene's top competitors are
Regenerative Industrial,
Jade Garment,
O'rental Car Services,
Pharmanovia,
Infineon Technologies,
Cellkey Ai,
Graphene Square Inc.,
London Innovators,
Bio Graphene Solutions,
Biographe.
Biographene's categories are Pharmaceutical Manufacturing
Biographene's founding year is 2017
